Putting Active Drugs in the Right Place at the Right Time”
David Cox M.D., Ph.D. Senior Vice President, Rinat/Pfizer
“Human Genetics, Precision Medicine and Improved Health Outcomes”
10:55- coffee break
John Murphy, Ph.D. Director, Molecular Biology and Protein Expression, Bayer HealthCare
“Engineering post-translational modifications to improve efficacy of recombinant Factor VIIa”
Randall Halcomb, Ph.D.